{"id":"W2116142233","doi":"10.3747/co.19.891","title":"Role of Pemetrexed in Sdvanced Non-Small-Cell Lung Cancer: Meta-Analysis of Randomized Controlled Trials, with Histology Subgroup Analysis","year":2012,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Credit Valley Hospital","funders":"","keywords":"Pemetrexed; Medicine; Internal medicine; Lung cancer; Hazard ratio; Oncology; Chemotherapy; Histology; Randomized controlled trial; Placebo; Confidence interval; Pathology; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":{"n_in":0,"stratum":"aff_core","weight":5595.2375,"opus":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"Meta-analysis of randomized trials of pemetrexed in non-small-cell lung cancer; a synthesis method used to answer a clinical question, the paradigm OUT case in the rubric."},"gpt":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"The meta-analysis answers a clinical treatment question rather than studying how meta-analyses are done."},"grok":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"Clinical meta-analysis of pemetrexed for lung cancer; method used to answer a treatment question."}}}